2021 year-end wrapup
Industry insights: obstacles, positives, and looking ahead
Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.
Archives for December 16, 2021
2021 year-end wrapup
Signant Health: consider DCT design factors from the start
While the pandemic saw many trials to shift to decentralized midstream, an expert from the trial tech firm suggests a ground-up design approach is preferable.
2021 year-end wrapup
‘Data transformation’ helping adverse event case processing: IQVIA
A leader from the company discusses how advanced analytical tools can be put to work to help tackle adverse event case processing and compliance issues.
2021 year-end wrapup
Pandemic leads to challenges, opportunities in drug development: ACD/Labs
A leader from the R&D tech provider discusses the obstacles faced by drug development professionals in recent months, and ways they rose to the occasion.
2021 year-end wrapup
Risk-based approach driving manufacturing improvements: Cognizant
A leader from the information technology specialist explains how evolved thinking and digital transformation are leading to benefits across the industry.
2021 year-end wrapup
Technology ‘culture of adoption’ vital for industry future: DTRA
A leader from the Decentralized Trials and Research Alliance offers perspective on the tools, technology, and thinking needed to advance clinical research.